Skip to main content
Top
Published in: Calcified Tissue International 4/2020

01-10-2020 | Computed Tomography | Original Research

Micro-computed Tomography Study of Frontal Bones in Males and Females with Hyperostosis Frontalis Interna

Authors: Danica Cvetković, Jelena Jadžić, Petar Milovanović, Danijela Djonić, Marija Djurić, Djurdja Bracanović, Slobodan Nikolić, Vladimir Živković

Published in: Calcified Tissue International | Issue 4/2020

Login to get access

Abstract

Hyperostosis frontalis interna (HFI) represents irregular thickening of the endocranial surface of the frontal bone, mostly seen in postmenopausal females. The microarchitecture of this condition is poorly studied. The aim of this cross-sectional autopsy study was to investigate and compare microarchitectural structure of the frontal bone affected with HFI in both sexes and to test whether HFI severity could be distinguished at the microarchitectural level. The sample was taken from human donor cadavers, 19 males (61 ± 15 years old) and 17 females (75 ± 15 years old). After classification of HFI severity (type A, B, C or D), samples of the frontal bone were taken and scanned using micro-computed tomography. Bone volume fraction was higher and total porosity lower only in the outer table of males with HFI, compared to females with HFI. Mean total sample thickness differed only between males with HFI type A and D. Bone microarchitecture between males and females with corresponding HFI types (e.g., male with type A versus female with type A) differed only in HFI type C regarding the fractal dimension of diploe. The degree of anisotropy differed between HFI subtypes in males, but the post hoc analysis revealed no significant differences between individual groups. Other microarchitectural parameters did not differ among males with different HFI subtypes, as well in females, in any part of the frontal bone. There is no difference in microarchitectural structure of the frontal bone between males and females with HFI, in general aspect and within corresponding HFI subtypes. HFI severity could not be distinguished at the microarchitectural level, neither in males nor in females.
Literature
1.
go back to reference Brickley M, Mays S (2019) Hyperostosis frontalis interna. In: Buikstra J (ed) Ortner’s identification of pathological conditions in human skeletal remains, 3rd edn. Academic Press, San Diego, pp 531–566CrossRef Brickley M, Mays S (2019) Hyperostosis frontalis interna. In: Buikstra J (ed) Ortner’s identification of pathological conditions in human skeletal remains, 3rd edn. Academic Press, San Diego, pp 531–566CrossRef
5.
6.
go back to reference Sheaff M, Hopster D (2005) Post mortem technique handbook, 2nd edn. Springer, London Sheaff M, Hopster D (2005) Post mortem technique handbook, 2nd edn. Springer, London
7.
go back to reference Salmi A, Vuotilainen A, Holsti LRUC (1962) Hyperostosis cranii in a normal population. Am J Roentgenol 87:1032–1040 Salmi A, Vuotilainen A, Holsti LRUC (1962) Hyperostosis cranii in a normal population. Am J Roentgenol 87:1032–1040
8.
go back to reference Dann S (1951) Metabolic craniopathy: a review of the literature with report of a case with diabetes mellitus. Ann Intern Med 34:163–202CrossRef Dann S (1951) Metabolic craniopathy: a review of the literature with report of a case with diabetes mellitus. Ann Intern Med 34:163–202CrossRef
9.
go back to reference Moore (1944) Metabolic craniopathy. Am J Roentgenol 35:30–39 Moore (1944) Metabolic craniopathy. Am J Roentgenol 35:30–39
10.
go back to reference Fulton JD, Shand J, Ritchie D, McGhee J (1990) Hyperostosis frontalis interna, acromegaly and hyperprolactinaemia. Postgrad Med J 66:16–19CrossRef Fulton JD, Shand J, Ritchie D, McGhee J (1990) Hyperostosis frontalis interna, acromegaly and hyperprolactinaemia. Postgrad Med J 66:16–19CrossRef
16.
go back to reference Gershon-Cohen J, Schraer HBN (1955) Hyperostosis frontalis interna among the aged. Am J Roentgenol 63:396–397 Gershon-Cohen J, Schraer HBN (1955) Hyperostosis frontalis interna among the aged. Am J Roentgenol 63:396–397
17.
go back to reference Schneeberg NG, Woolhandler GLR (1947) The clinical significance of hyperostosis frontalis interna. J Clin Endocrinol 7:624–635CrossRef Schneeberg NG, Woolhandler GLR (1947) The clinical significance of hyperostosis frontalis interna. J Clin Endocrinol 7:624–635CrossRef
23.
go back to reference Miazgowski T, Eisner M, Czekalski S (1991) Kallman’s syndrome combined with aortic valve anomaly and epilepsy. Pol Tyg Lek 46:380–382PubMed Miazgowski T, Eisner M, Czekalski S (1991) Kallman’s syndrome combined with aortic valve anomaly and epilepsy. Pol Tyg Lek 46:380–382PubMed
28.
go back to reference She R, Szakacs J (2004) Hyperostosis frontalis interna: case report and review of literature. Ann Clin Lab Sci 34:206–208PubMed She R, Szakacs J (2004) Hyperostosis frontalis interna: case report and review of literature. Ann Clin Lab Sci 34:206–208PubMed
Metadata
Title
Micro-computed Tomography Study of Frontal Bones in Males and Females with Hyperostosis Frontalis Interna
Authors
Danica Cvetković
Jelena Jadžić
Petar Milovanović
Danijela Djonić
Marija Djurić
Djurdja Bracanović
Slobodan Nikolić
Vladimir Živković
Publication date
01-10-2020
Publisher
Springer US
Published in
Calcified Tissue International / Issue 4/2020
Print ISSN: 0171-967X
Electronic ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-020-00730-2

Other articles of this Issue 4/2020

Calcified Tissue International 4/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.